🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 122,22 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 148,73 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 1 día
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 28/11/1977 | 0,0113 USD |
| 29/08/1977 | 0,0099 USD |
| 31/05/1977 | 0,0099 USD |
| 01/03/1977 | 0,0099 USD |
| 30/11/1976 | 0,0099 USD |
| 30/08/1976 | 0,0093 USD |
| 01/06/1976 | 0,0093 USD |
| 02/03/1976 | 0,0093 USD |
| 01/12/1975 | 0,0093 USD |
| 29/08/1975 | 0,0093 USD |
| 02/06/1975 | 0,0093 USD |
| 03/03/1975 | 0,0093 USD |
| 30/08/1974 | 0,0093 USD |
| 03/06/1974 | 0,0093 USD |
| 04/03/1974 | 0,0093 USD |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 23/09/2022 | 87,40 | 88,01 | 86,09 | 86,78 | -0,83% | 2,20% | 9.038.500 |
| 22/09/2022 | 84,55 | 88,15 | 84,55 | 87,51 | +3,53% | 4,26% | 12.329.700 |
| 21/09/2022 | 86,25 | 86,50 | 84,52 | 84,53 | -1,71% | 2,30% | 7.190.800 |
| 20/09/2022 | 86,07 | 86,45 | 85,59 | 86,00 | -0,74% | 1,00% | 5.454.800 |
| 19/09/2022 | 86,85 | 86,94 | 85,64 | 86,64 | -1,23% | 1,50% | 7.748.600 |
| 16/09/2022 | 86,60 | 87,87 | 86,40 | 87,72 | +1,12% | 1,70% | 14.842.500 |
| 15/09/2022 | 87,15 | 87,43 | 86,20 | 86,75 | -0,23% | 1,41% | 8.006.800 |
| 14/09/2022 | 87,00 | 87,64 | 86,38 | 86,95 | +0,78% | 1,45% | 9.418.700 |
| 13/09/2022 | 87,32 | 87,61 | 86,11 | 86,28 | -2,13% | 1,72% | 7.650.000 |
| 12/09/2022 | 88,13 | 89,17 | 87,82 | 88,16 | +0,94% | 1,53% | 6.351.500 |
| 09/09/2022 | 87,59 | 88,17 | 87,27 | 87,34 | -0,09% | 1,03% | 7.480.100 |
| 08/09/2022 | 86,50 | 87,45 | 86,13 | 87,42 | +0,63% | 1,53% | 8.109.200 |
| 07/09/2022 | 86,56 | 87,00 | 85,07 | 86,87 | +0,52% | 2,23% | 6.121.700 |
| 06/09/2022 | 86,58 | 87,27 | 86,16 | 86,42 | +0,22% | 1,28% | 8.244.300 |
| 02/09/2022 | 87,24 | 87,78 | 85,88 | 86,23 | -1,06% | 2,18% | 6.997.500 |
| 01/09/2022 | 85,64 | 87,46 | 85,36 | 87,15 | +2,10% | 2,45% | 7.528.600 |
| 31/08/2022 | 87,04 | 87,13 | 85,16 | 85,36 | -1,75% | 2,26% | 11.602.000 |
| 30/08/2022 | 87,47 | 87,57 | 86,58 | 86,88 | -0,81% | 1,13% | 6.754.000 |
| 29/08/2022 | 88,83 | 89,00 | 87,56 | 87,59 | -1,87% | 1,62% | 7.850.200 |
| 26/08/2022 | 90,28 | 90,74 | 89,09 | 89,26 | -1,12% | 1,83% | 5.695.300 |
| 25/08/2022 | 90,51 | 90,51 | 89,07 | 90,27 | +0,29% | 1,59% | 5.884.300 |
| 24/08/2022 | 90,20 | 90,32 | 89,54 | 90,01 | -0,21% | 0,86% | 5.553.300 |
| 23/08/2022 | 90,88 | 90,99 | 89,72 | 90,20 | -1,05% | 1,40% | 5.208.800 |
| 22/08/2022 | 91,81 | 92,22 | 91,01 | 91,16 | -1,00% | 1,32% | 6.652.100 |
| 19/08/2022 | 91,55 | 93,02 | 91,53 | 92,08 | +0,74% | 1,63% | 8.828.700 |
| 18/08/2022 | 91,50 | 91,84 | 90,53 | 91,40 | +0,40% | 1,43% | 6.111.600 |
| 17/08/2022 | 90,34 | 91,89 | 90,30 | 91,04 | +0,50% | 1,76% | 6.486.000 |
| 16/08/2022 | 89,96 | 90,90 | 89,87 | 90,59 | -0,01% | 1,14% | 5.661.200 |
| 15/08/2022 | 90,83 | 90,84 | 89,89 | 90,60 | -0,46% | 1,05% | 6.339.800 |
| 12/08/2022 | 88,99 | 91,03 | 88,95 | 91,02 | +2,35% | 2,34% | 12.317.300 |